SCIT Allergy Shots: Your Subcutaneous Immunotherapy Quick-Reference Guide
SCIT — subcutaneous immunotherapy — is the clinical abbreviation for allergy shots. The protocol has two phases: build-up (weekly injections for 3-6 months) and maintenance (every 2-4 weeks for 3-5 years). A 2007 Cochrane review found SCIT reduces rhinitis symptoms by 33% and medication use by 36%. Disease-modifying effects persist 7-12 years after completing treatment.
6 peer-reviewed sources
SCIT is the medical abbreviation for allergy shots — subcutaneous immunotherapy. Weekly injections for 3-6 months build up to a maintenance dose, then monthly shots continue for 3-5 years.
What SCIT Means and What the Full Treatment Arc Looks Like
SCIT is the abbreviation for subcutaneous immunotherapy — the formal medical and insurance term for what patients call allergy shots. European allergists often use the broader abbreviation AIT (allergen immunotherapy), which encompasses both SCIT and SLIT (sublingual immunotherapy). If you have seen SCIT on an insurance prior authorization form, a referral letter, or a treatment summary, it simply means allergy shots.
The SCIT protocol, defined by the AAAAI/ACAAI Joint Task Force Practice Parameter (Cox et al., JACI 2011), consists of two phases. During the build-up phase, patients receive one to two injections per week for approximately 3-6 months, with the allergen dose increasing at each visit from a very dilute starting concentration (typically 1,000-10,000 times below the maintenance dose) up to the therapeutic maintenance concentration. During the maintenance phase, injections are spaced every 2-4 weeks and continued for 3-5 years. After every injection there is a 30-minute observation window because approximately 85% of systemic reactions occur within it. Traditionally this was done in the office; today, for eligible maintenance patients, at-home SCIT through Curex keeps the same window while a prescribed epinephrine auto-injector is confirmed on hand and the first injection and every dose change are supervised live over Zoom.
For patients exploring whether SCIT is appropriate, comprehensive allergy testing is the first step — it identifies the specific IgE-mediated triggers that will be targeted. At-home testing through Curex covers 40+ allergens and can clarify the allergen profile before a patient commits to a 3-5 year treatment plan.
The disease-modifying effects of a completed SCIT course are unique in allergy medicine — Durham et al. (NEJM 1999) demonstrated that 3-4 years of grass pollen SCIT produces clinical remission persisting at least 3 years after stopping treatment, and the PAT 10-year follow-up showed protection against asthma development persisting 7 years post-treatment (Jacobsen et al., Allergy 2007).
SCIT is a 3-5 year commitment, but it is the only allergy treatment with documented disease modification — benefits that persist years after stopping, including reduced risk of new sensitizations and asthma development in children.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
The SCIT Treatment Arc: Build-Up Through Sustained Benefit
The SCIT treatment arc spans several years, but benefits typically begin within the first year of reaching the maintenance dose. Understanding the three phases helps patients set realistic expectations and stay committed through the full course — adherence is the single biggest predictor of outcome, with real-world data showing only 23% of patients complete the recommended 3 years (Kiel et al., JACI 2013).
Starting from a highly diluted allergen concentration (typically 1:10,000 of the maintenance concentrate), the dose is increased at each visit through a series of vials. Most patients require approximately 25-30 injections to reach the maintenance dose. Faster protocols (cluster: 4-8 weeks; rush: 1-3 days) are available but carry higher systemic reaction rates. Each visit takes about 45 minutes including the mandatory 30-minute observation period.
Once the therapeutic maintenance dose is reached (typically 5-20 micrograms of major allergen for inhalant allergens per the JTFPP 2011), injections are spaced to every 2-4 weeks. About 73% of US allergists use a 4-week maintenance interval. Most patients begin noticing meaningful symptom improvement within the first year of maintenance. If no benefit is observed after 1 year of maintenance dosing, the AAAAI/ACAAI guidelines recommend reassessing the treatment plan.
After completing a full 3-5 year SCIT course, disease-modifying immune changes persist significantly longer than treatment duration. Durham et al. (NEJM 1999) showed no relapse at 3 years post-discontinuation after a 3-4 year grass pollen course. PAT 10-year data demonstrated that childhood SCIT reduced asthma development 7 years after stopping. For patients who relapse, a second course of SCIT is an option and typically works more rapidly than the first.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youAt-Home SCIT vs SLIT: Choosing the Right Immunotherapy Format
SCIT and SLIT (sublingual immunotherapy) share the same evidence-based biological goal — allergen-specific tolerance — but differ in delivery, safety profile, and practical burden. Patients who understand SCIT but want to avoid weekly clinic trips no longer have to switch modalities: at-home SCIT through Curex delivers the same allergy-shot immunotherapy with safeguards, for eligible maintenance patients.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Allergy Shots (SCIT, Curex) — RECOMMENDEDBest | 33% symptom reduction vs placebo; 7-12 year post-treatment benefit | 3-5 years; weekly at-home self-injection (build-up doses Zoom-supervised) | $3,000-$15,000 depending on insurance | At-home weekly self-injection with Curex; brief 30-min self-observation per dose; no clinic trips during maintenance | 0.1% systemic reaction rate; prescribed epinephrine on hand, first dose and changes Zoom-supervised |
Sublingual Drops (SLIT) | Comparable to SCIT in network meta-analyses; same 3-year minimum | 3-5 years; daily drops at home | $468-$3,600 depending on provider | Fully at home after initial prescription; no needles, no clinic | Zero documented fatalities worldwide; local oral reactions predominate |
- Efficacy
- 33% symptom reduction vs placebo; 7-12 year post-treatment benefit
- Duration
- 3-5 years; weekly at-home self-injection (build-up doses Zoom-supervised)
- Cost (5yr)
- $3,000-$15,000 depending on insurance
- Convenience
- At-home weekly self-injection with Curex; brief 30-min self-observation per dose; no clinic trips during maintenance
- Safety
- 0.1% systemic reaction rate; prescribed epinephrine on hand, first dose and changes Zoom-supervised
- Efficacy
- Comparable to SCIT in network meta-analyses; same 3-year minimum
- Duration
- 3-5 years; daily drops at home
- Cost (5yr)
- $468-$3,600 depending on provider
- Convenience
- Fully at home after initial prescription; no needles, no clinic
- Safety
- Zero documented fatalities worldwide; local oral reactions predominate
Patients who want SCIT without the clinic schedule can get it directly: Curex delivers at-home SCIT at $129/month — the same subcutaneous immunotherapy described above, self-administered weekly. A board-certified allergist reviews your 40+ allergen at-home test, confirms candidacy, and supervises your first injection and every dose change live over Zoom; the personalized serum is sterile-compounded to USP <797> standards and a prescribed epinephrine auto-injector is confirmed on hand before you begin.
See if at-home shots are right for youFrequently asked questions
What does SCIT stand for in allergy?
SCIT stands for subcutaneous immunotherapy — the formal medical abbreviation for allergy shots. 'Subcutaneous' refers to the injection route (into the fatty tissue layer beneath the skin), and 'immunotherapy' describes the treatment goal of retraining the immune system rather than just suppressing symptoms. In European allergy literature, the broader term AIT (allergen immunotherapy) is often used to encompass both SCIT and SLIT (sublingual immunotherapy). On insurance forms and prior authorization requests, you may see CPT codes 95165 (antigen preparation) and 95115 or 95117 (injection administration) associated with SCIT claims.
How many allergy shots do you need total?
A full SCIT course typically involves 60-100 or more injections over 3-5 years. During build-up (3-6 months), approximately 25-30 weekly or twice-weekly injections are needed to reach the maintenance dose. During the maintenance phase (3-5 years), injections occur every 2-4 weeks — adding roughly 12-18 injections per year. Over a 3-year course, total injection count is approximately 57-65; over 5 years, approximately 85-95. Cluster protocols (multiple doses per visit over 4-8 weeks) can compress the build-up phase but do not change the maintenance schedule.
What is the difference between SCIT and SLIT?
SCIT (subcutaneous immunotherapy, allergy shots) and SLIT (sublingual immunotherapy, drops or tablets) both retrain the immune system to tolerate allergens but differ in delivery route and practical experience. Traditional clinic SCIT involves weekly visits during build-up then monthly maintenance, each with a 30-minute post-injection observation; with at-home SCIT through Curex, eligible maintenance patients self-administer the same shots at home, with the first dose and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector on hand. SLIT is taken as dissolvable tablets or drops under the tongue at home daily, after an initial supervised dose. Efficacy is broadly comparable per network meta-analyses (Nelson et al., 2015) for grass and HDM. SLIT has a substantially better safety profile — zero documented fatalities worldwide versus approximately 1 per 2.5 million injections for SCIT historically. SCIT has broader allergen coverage across all major environmental triggers.
When does SCIT start working?
Most patients notice meaningful symptom improvement within 3-6 months of starting SCIT, often coinciding with approaching or reaching the maintenance dose. The AAAAI/ACAAI Practice Parameter (Cox et al., JACI 2011, Summary Statement 44) states that 'clinical improvement usually is observed within 1 year after the patient reaches a maintenance dose.' Some patients with milder sensitization experience earlier benefit; others with complex multi-allergen profiles may require 12-18 months of maintenance dosing before full benefit is apparent. If no benefit is observed after 1 year of maintenance, the guidelines recommend reconsidering whether SCIT is appropriate for that patient.
Can you stop SCIT after 3 years?
Three years is the evidence-based minimum for sustained post-treatment benefit, and many patients successfully discontinue after 3-4 years while maintaining clinical remission. Durham et al. (NEJM 1999) demonstrated that patients who completed 3-4 years of grass pollen SCIT showed no meaningful symptom difference from those who continued maintenance for an additional 3 follow-up seasons. Some patients — particularly those with more severe disease, multiple sensitizations, or incomplete symptom control — may benefit from extending treatment to 4-5 years. The decision to stop should be made in consultation with the treating allergist based on symptom trajectory and immunological response.
What are cluster and rush SCIT protocols?
Cluster SCIT administers 2-3 progressively higher doses in a single visit (spaced about 30 minutes apart), reducing build-up time to approximately 4-8 weeks instead of 3-6 months (Calabria, Ann Allergy Asthma Immunol 2023). Rush SCIT compresses build-up to 1-3 days, with injections given every 15-60 minutes under close medical supervision and with premedication (antihistamines, often corticosteroids). Rush requires a monitored clinical setting due to elevated systemic reaction rates. Both protocols maintain the same 3-5 year maintenance phase. Cluster is increasingly popular for motivated patients who want faster symptom benefit; rush is reserved for specific clinical situations where rapid protection is needed.
Are allergy shots safe for patients with asthma?
SCIT is indicated for patients with allergic asthma that is controlled and stable, but requires careful monitoring. Uncontrolled or severe asthma — typically defined as FEV1 below 70% predicted — is a relative-to-absolute contraindication because poor lung function substantially increases systemic and fatal reaction risk. Four of 7 fatalities identified in the AAAAI/ACAAI surveillance study (2008-2016) occurred in patients with asthma. Before each injection visit, patients with asthma should have their peak flow measured and their asthma symptoms assessed. Allergy immunotherapy has been shown to reduce asthma exacerbations and medication use when properly administered, making it a valuable long-term treatment for patients with well-controlled allergic asthma.
What happens if you miss a maintenance allergy shot?
Missing maintenance injections typically requires a dose adjustment based on how long since the last shot. For gaps up to about 5 weeks, the maintenance dose can usually be continued normally. Gaps of 5-7 weeks typically require a 25% dose reduction; 7-11 weeks may require stepping back by one dose concentration (approximately 45% reduction). Gaps of 3 months or more in maintenance generally require restarting SCIT from the beginning, because the immune tolerance induced by prior injections has waned significantly. A 2025 surveillance analysis found that practices that reduced by one full vial for patients more than 7 weeks late had significantly lower grade-4 systemic reaction rates — confirming that dose adjustment after gaps is clinically important, not just precautionary.
Related Articles
Are Allergy Shots Subcutaneous or Intramuscular? | Curex
Allergy shots are always subcutaneous, never intramuscular. Learn the clinical reasons why IM is avoided and what systemic reaction risks it would carry.
Read moreImmunotherapy for Allergy: How It Rewires Immunity | Curex
Immunotherapy for allergy reprograms immunity via FOXP3+ Tregs and IgG4 blocking antibodies. Learn how the immune cascade leads to lasting allergy relief.
Read moreWhat Is Allergy Shots? Quick Definition and How It Works
What is allergy shots? SCIT trains your immune system to tolerate allergens over 3-5 years. 85-90% of patients see significant improvement.
Read moreAllergy Shot Side Effects: Per-Injection Timeline | Curex
What happens after each allergy shot? A minute-by-minute timeline from the 30-min wait to 48-hour local reactions, with safety thresholds and real data.
Read moreAllergy Immunotherapy Guide: All Options Compared | Curex
Allergy immunotherapy covers shots, tablets, drops, and OIT. Compare SCIT vs SLIT on efficacy, safety, cost, and FDA status to choose the right route.
Read moreAllergy Shots: Complete SCIT Guide for Patients | Curex
Allergy shots (SCIT) reduce symptoms by 33-85% over 3-5 years. Learn how they work, what they cost, and who qualifies for this disease-modifying treatment.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.